학술논문

Efficacy of artemether–lumefantrine versus dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial.
Document Type
Article
Source
Transactions of the Royal Society of Tropical Medicine & Hygiene; Jun2019, Vol. 113 Issue 6, p312-319, 8p
Subject
THERAPEUTICS
MALARIA
HEALTH facilities
Language
ISSN
00359203
Abstract
The article offers a study on the efficacy of Artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DHP). It mentions Artemether–lumefantrine (AL) was introduced in 2005 as a first-line Artemisinin-based combination therapies (ACT) for the treatment of uncomplicated malaria in Rwanda; and also mentions DHP demonstrated a greater post-treatment prophylactic effect against new infections compared with AL.